Plain-English translation of NCT06662058 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Head and neck cancer patients receiving cisplatin chemotherapy and/or radiation can experience hearing loss as a side effect. This trial is testing whether offering hearing tests at home or at a location closer to patients' homes—rather than requiring all tests at the main hospital—will help more people monitor their hearing throughout and after treatment. The study wants to understand how often and how severe this hearing loss occurs, and what makes it easier for patients to participate in monitoring.
Hearing loss from cancer treatment is a real concern, but many patients skip their hearing check appointments because traveling to the hospital is inconvenient or expensive. This trial exists to find out if making these tests more accessible—by offering remote or local options—will help more patients stay on top of their hearing health during a challenging time.
You likely qualify if…
You likely don't qualify if…
You will have a baseline hearing test at Emory's Winship Midtown location. Depending on where you live and the stage of your cancer, you may either return to the same hospital location for follow-up tests at 3 and 12 months after your chemotherapy and/or radiation, or you may be offered the choice of a hearing test closer to home or a self-administered remote hearing test at those same time points. The study is designed to make hearing monitoring fit your life, not the other way around.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States